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Abstract
A new method of analysis has been developed and validated for the determination of thiafentanil
in plasma. After protein precipitation, samples were separated on an XBridge BEH C18 column and
quantified using mass spectrometry. The mobile phase was a mixture of water with 0.1% formic
acid and acetonitrile with 0.1% formic acid (90:10). The standard curve ranged from 0.1 to 25 ng/mL.
Intra- and Inter-assay variability for thiafentanil was less than 10%, and the average recovery was
greater than 95%. The lower limit of quantification was 0.1 ng/mL. This is the first validated method
for thiafentanil analysis in plasma.
Introduction
Opioid agonists are valuable for immobilization of many nondo-
mestic species. Opioids such as etorphine and carfentanil are often
preferred for their potency, fast action and ability to have their effects
reversed. However, this class of drug is associated with adverse side
effects such as excitement, muscle rigidity, regurgitation, bradypnea,
abnormal blood pressure, hyperthermia and lactic acidosis (1).
Thiafentanil is a potent opioid that is a synthetic fentanyl deriva-
tive, structurally similar to sufentanil. It has a morphine-like anal-
gesic mode of action and produces rapid immobilization following
intramuscular injection. It is used for immobilization of captive minor
species and free-ranging hoof stock and represents the next genera-
tion of opioid immobilizing agents. The restraint and immobilization
of nondomestic ungulates has been extremely problematic and there
continues to be a need for agents that will immobilize these animals
quickly and safely (2). When compared to other opioids, thiafentanil
has a much shorter induction time, by as much as 50%, while
retaining agonist activity (3). In addition, recovery times after antago-
nization are also shorter (4). Because it has a shorter half-life, there is
less incidence of renarcotization, which is the reoccurrence of opioid
effects after apparent antagonism. Renarcotization is dangerous for
free-ranging wildlife because prolonged struggling during recovery
could cause several life-threatening problems, such as hyperthermia
and trauma (2). The shorter half-life also means that targeted animals
may be handled and secured quicker than with other opioids, prevent-
ing problems with trauma, overheating and escapes by free-ranging
wildlife.
A literature search revealed no published methods for the deter-
mination of thiafentanil in plasma. Therefore, the aim of this paper
was to develop a simple, sensitive, specific and reliable method for




The chromatography system consisted of an Acquity Arc system and
an Acquity QDa single-quadrupole mass detector (Waters, Milford,
MA). Separation occurred on an XBridge BEH C18 column (4.6 ×
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Figure 1. Structures of thiafentanil and fentanyl.
(3.9 × 5 mm). The mobile phase was a mixture of (A) 0.1% formic
acid in water and (B) 0.1% formic acid in acetonitrile (90:10, v/v).
The mixture was pumped at a starting ratio of 90% A and 10% B and
then changes to 10% A and 90% B over 4 minutes and then returns to
initial conditions over 3 minutes. The flow rate was 0.6 mL/min and
the column temperature was 30◦C. The compounds were detected
by positive selected ion recording. The scan rate was 5 points/second,
gain 10, capillary voltage 0.8 kV, cone voltage for thiafentanil 8, cone
voltage for fentanyl 15, ion source temperature 150◦C and probe
temperature 600◦C. Nitrogen was used as the nebulizing gas and
maintained at 100 psi. Thiafentanil was detected at 417 m/z and
fentanyl was detected at 337 m/z.
Thiafentanil (Figure 1) (Wildlife Pharmaceuticals Inc., Windsor,
CO) was 98% pure. Fentanyl (Figure 1), which was the internal
standard (99% purity) was purchased from US Pharmacopeia
(Rockville, MD). All other mass spectrometry grade chemicals and
solvents were purchased from Fisher Scientific (Pittsburg, PA). Water
(18.2 megaohm) was obtained from a Barnstead Nanopure Infinity
(Dubuque, IA) ultrapure water system.
Preparation of calibration standards
Five milligrams of thiafentanil or fentanyl were weighed and dis-
solved in methanol to produce stock concentrations of 100 μg/mL.
Dilutions of the stock standards were prepared in methanol to
produce 0.01, 0.1 and 1 μg/mL working stock solutions. Standards
were aliquoted into 2 mL vials to prevent cross contamination and
evaporation. All solutions were stored at 4◦C. By comparing standard
areas over time, it was determined that solutions were stable for a
minimum of 8 months.
For preparation of calibration standards and quality control
samples, appropriate volumes of stock solutions were placed in 13
× 100 mm glass tubes and evaporated with nitrogen then untreated
plasma was added.
Sample preparation
Thiafentanil was extracted from plasma using a protein precipitation
method. One hundred microliters of plasma was placed in a 13
× 100 mm tube followed by 5 μL of fentanyl (0.1 μg/mL) and
then 1 mL of acetonitrile. Tubes were vortexed at high speed for
60 seconds and then centrifuged for 10 minutes at 1020 × g. The
supernatant was removed and placed in a 13 x 100 mm glass tube and
evaporated to dryness with nitrogen. Samples were reconstituted in
200 μL of mobile phase, vortexed and then placed in a total recovery
chromatographic vial and 65 μL injected into the system.
Method validation
The method was validated according to the Guidelines for Bioanalyt-
ical Method Validation published by the Food and Drug Administra-
tion (5). Validation of the method was carried out using QC samples.
All of the QC samples and calibration curves were prepared in a
plasma matrix. The validation process looked at accuracy, precision,
selectivity, sensitivity, reproducibility and stability.
Selectivity
Selectivity was determined by injecting blank plasma from six differ-
ent deers to confirm no interfering peaks around the retention time
of both thiafentanil and fentanyl, the internal standard (IS).
Calibration curve, linearity and quality control samples
The final concentrations for the calibration standard curve were 0.1,
0.25, 0.5, 1, 2.5, 5, 10 and 25 ng/mL. The calibration curve was
constructed by using the ratio of the peak area of the analyte divided
by the peak area of the internal standard versus the concentration
and obtained on five different days. Linearity was assessed by linear
regression analysis and expressed as the coefficient of determination
(r2). The standard deviations (SD) of the slope, intercepts and regres-
sion coefficient were calculated. The QC samples were prepared in a
similar manner as the calibration standards at four different levels
0.3, 0.75, 3.5 and 17.5 ng/mL. The acceptance criterion for each
back-calculated standard was 15% deviation from the nominal value
except lower limit of quantification (LLOQ), which was set at 20%.
Accuracy, precision and recovery
The precision and accuracy of the assay were determined using QC
samples of known thiafentanil concentrations (0.3, 0.75, 3.5 and
17.5 ng/mL), which were processed freshly each validation day. Five
replicates of each QC were analyzed during the same day and on
five different days, and the intra- and inter-assay means, SD and
coefficient of variation were calculated. Recoveries were calculated as
the measured concentrations divided by the expected concentrations
and expressed as a percentage (5). The tailing factor was calculated
by As = W0.05/2f , where W0.05 is the width of the peak at 5% height
and f is the distance from the peak maximum to the leading edge of
the peak height from the baseline (6).
Results
Selectivity
Endogenous components from the plasma did not interfere with the
elution of the compounds of interest. Six different blank plasmas were
used in the pre-validation process. Figure 2 shows chromatograms of
a (A) blank plasma, (B) a 0.5 ng/mL spiked plasma standard and (C)
a plasma sample from a deer 30 minutes after a 0.07 mg/kg dose via
nonmetal dart administration. Retention times were 4.32 minutes for
thiafentanil and 4.56 minutes for fentanyl.
Calibration curves, precision, accuracy and linearity
The plasma peak area ratio (area of thiafentanil divided by internal
standard area) versus concentration was plotted and produced a
linear curve for the concentration range used (0.1–25 ng/mL) with
the correlation coefficients ranging from 0.9990 to 0.9998. The mean
slopes, intercepts and r2 values are reported in Table I. A typical linear
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Figure 2. Chromatograms for a (A) blank plasma, (B) a plasma standard spiked with 0.5 ng/mL thiafentanil and IS, and (C) a plasma sample from a deer 30 minutes
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(ng/mL) (mean ± SD)
RSD (%) Accuracy (%)
(mean ± SD)
0.3 0.36 ± 0.03 8.3 120 ± 9
0.75 0.72 ± 0.05 7.5 96 ± 7
3.5 3.3 ± 0.31 9.6 94 ± 5
17.5 18.6 ± 0.84 4.5 106 ± 5
Assay linearity (n = 5)
Mean ± SD RSD (%)
Y-Intercept 0.0360 ± 0.0010 2.7
Slope 0.0682 ± 0.0011 0.5
r 2 0.9990 ± 0.0005 0.05
SD: standard deviation; n: number of samples; RSD: relative standard deviation
Table II. Inter-assay variability and recovery for thiafentanil in






RSD (%) Accuracy (%)
(mean ± SD)
Recovery (%)
0.3 0.31 ± 0.01 4.7 103 ± 5 100
0.75 0.77 ± 0.03 3.6 103 ± 3 109
3.5 3.5 ± 0.13 4.8 100 ± 4 103
17.5 17.6 ± 0.32 1.8 100 ± 3 99
SD: standard deviation; n: number of days; RSD: relative standard deviation
where y represents the peak area ratio of thiafentanil to internal stan-
dard and x represents the concentration of thiafentanil in nanograms
per milliliter.
All values of accuracy and precision were within the recom-
mended limits. Intra-assay precision ranged from 4.5 to 9.6%, while
inter-assay precision ranged from 1.8 to 4.1%, respectively. These
precision values are well below the set ±15% for all quality control
samples as shown in Tables I and II. The intra-assay accuracy ranged
from 94 to 120% and inter-assay accuracy ranged from 100 to 103%,
respectively.
The thiafentanil peaks were slightly asymmetrical but the USP
tailing factor was 1.52. Numbers ≤ 2 are considered acceptable.
Recovery, LLOQ and stability
The recovery of thiafentanil was determined by comparing the peak
areas of extracted analytes with that of the directly injected stan-
dard solutions. The average recovery of thiafentanil from the four
plasma QC concentrations ranged from 99 to 109%. The average
recovery of fentanyl was 91%. The LLOQ was 0.1 ng/mL, which
represents a peak approximately five times baseline noise. The LOD
was 0.05 ng/mL, which represents a peak three times baseline noise.
The baseline noise was calculated using the peak to peak method.
Testing of short-term stability of the quality control standards for
plasma indicated that there was a 2% loss of drug after 24 h in the
autosampler and 1% after 24 h at 4◦C. Samples in our studies were
stored at −80◦C and thawed once for analysis. After one freeze-thaw
cycle, there was no loss of thiafentanil.
Discussion
To the authors’ knowledge, we have developed and validated the first
method for the quantification of thiafentanil in plasma using reverse
phase separation and mass spectrometry detection. We wanted to
develop a simple, sensitive, straightforward method that would be
effective with small volume samples. Several organic solvents and
mixtures were tested during optimization of the extraction procedure
including, methanol, ethyl acetate, hexane, chloroform and methylene
chloride. All were found to produce much lower recoveries compared
to acetonitrile. The amount of acetonitrile used for the extraction
process was also investigated. Five hundred microliters, 1 and 1.5 mL
of acetonitrile were used for the precipitation process and it was
determined that the recovery decreased when using 0.5 mL and
remained the same with the 1.5 mL, therefore, we elected to use 1 mL.
The recovery and limit of quantification are more than adequate
for use in the determination of thiafentanil in plasma. If a lower
LLOQ is required, a larger sample volume could be used. There was
a 2% or less, sample loss after storage in either the autosampler or
the refrigerator; therefore, if there were a power or equipment failure,
samples could be reanalyzed. The validation indicates good intra- and
inter-assay precision and accuracy within the concentration range
used. The addition of fentanyl as an internal standard allows for the
correction of intra- and inter-assay variability.
Conclusion
In conclusion, this analytical procedure was validated in terms of
recovery, linearity, LLOQ, precision and accuracy. The procedure
employs a low plasma volume, which could make it beneficial if the
drug was used in smaller animals. The limit of quantification and
recovery are more than adequate for use in quantitation studies. Our
results indicate that this high performance liquid chromatography
mass spectrometry procedure is a reproducible method that provides
consistent quantification of thiafentanil in plasma. The addition of an
internal standard allows for the correction of intra- and inter-assay
variability. This method has been successfully applied to determine
thiafentanil concentrations in plasma samples at this institution. This
method should be applicable to other species.
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